Sekretessinställningar
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • BlankningSe vilka börsnoterade bolag som har offentliggjorda korta positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

Medclair receives a new order worth approximately 12 MSEK in the UK

MCLRRegulatoriskt pressmeddelande2026-08-20 08:32
Ladda ner börsmeddelandet

Medclair has received a new order from a leading player in the recycling sector. The order value amounts to approximately 12 MSEK and pertains to the UK market. Parts of the order include an installation in Scotland, which means that Medclair is establishing itself in a new geographical market.

Through the new order, Medclair continues to gain ground in the recycling sector, a segment where the company has built a stable and growing customer base in several European countries in recent years. With the installation in Scotland, Medclair's technology for the recycling sector is now in place in England, Scotland, Ireland, Belgium, France, Denmark, and Sweden.

The order confirms the demand Medclair sees in the recycling segment and strengthens the company's position as an established provider of solutions for nitrous oxide destruction for players in waste management and recycling in the UK and the rest of Europe.

"Taking on Scotland as a new market is clear proof that our technology for safe and sustainable nitrous oxide management is in broad demand within the recycling sector, both in the UK and in the rest of Europe. Recycling has in a short time developed into one of our most important growth areas, and together with dental and healthcare, we now have three stable business areas – industry, dental, and healthcare – to rely on in our continued expansion," says Jonas Lundh, CEO of Medclair.

Medclair's three business areas – industry, dental, and healthcare – provide the company with a broader revenue base and reduce its dependence on individual segments or markets. The recycling sector, which is part of the industry business area, has grown over the past year to become a significant part of the order intake and contributes to spreading the company's geographical and commercial risk.

Jonas Lundh
CEO
Medclair AB

For further information, please contact:
Jonas Lundh, Medclair AB (publ), Phone: +46 76 193 90 90, Email: jonas.lundh@medclair.com

About Us
Medclair is a Swedish cleantech company and a leader in safe and sustainable nitrous oxide management. With operations in twenty countries, Medclair provides innovative solutions that significantly reduce the climate impact of nitrous oxide while improving workplace safety.

The company is listed on NGM Nordic SME. For more information, please visit www.medclair.com.

This information is information that Medclair is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-08-20 08:32 CEST.

Attachments
Medclair receives a new order worth approximately 12 MSEK in the UK